grant
saveNOMOCAN PHARMACEUTICALS, LLC — NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR...
September 15, 2025updated 2mo ago
community read0 votes
CA grant. $499,166. PI: EHSAN YAZDI
view source ↗CA grant. $499,166. PI: EHSAN YAZDI
view source ↗
comments(0)
5-min edit window · permanent after that